<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy — Live Feed</title><link>https://www.live-feeds.com/feed/mo-attorney-general-sends-prescription-manufacturer-eli-lilly-cease-and-desist-over-drug-price-policy</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/mo-attorney-general-sends-prescription-manufacturer-eli-lilly-cease-and-desist-over-drug-price-policy/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Mo. AG Orders Eli Lilly to Halt 340B Data Policy</title><link>https://www.live-feeds.com/feed/mo-attorney-general-sends-prescription-manufacturer-eli-lilly-cease-and-desist-over-drug-price-policy</link><guid isPermaLink="false">https://www.live-feeds.com/feed/mo-attorney-general-sends-prescription-manufacturer-eli-lilly-cease-and-desist-over-drug-price-policy#u165042</guid><pubDate>Sat, 31 Oct 2026 07:32:01 +0000</pubDate><description>Missouri Attorney General Catherine Hanaway issued a cease-and-desist letter to drug manufacturer Eli Lilly, demanding the company halt its policy of requiring extensive claims data from hospitals seeking 340B drug discounts. Hanaway gave Eli Lilly until November 26 to comply, warning that the pricing conditions violate state law and harm eligible healthcare providers. The action follows a pricing dispute involving MU Health Care, and mirrors broader legal challenges from major hospital systems including MGH and Brigham, which have sued Eli Lilly over similar drug discount practices.Why it mat</description></item>
</channel></rss>